Eulerpool Terminal
The edge that pays for itself.
Current PharmaCorp Rx forecasts and price targets in July 2026
Ø Analyst Price Targets
0.66 CAD
+27.50 %
Median
0.66 CAD
+27.50 %
Max
0.68 CAD
Min
0.66 CAD
Last Price
0.52 CAD
Buy
4
Hold
1
Sell
0
The average target price for PharmaCorp Rx is 0.66 CAD. (+27.50 % above the current price)
The median price target of PharmaCorp Rx is 0.66 CAD.
Stock analysts from many renowned investment banks are closely examining the PharmaCorp Rx stock. They conclude their professional PharmaCorp Rx stock analyses with a clear recommendation for the PharmaCorp Rx stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
PharmaCorp Rx Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for PharmaCorp Rx in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 20.00 M CAD | — | — |
| 2026e | 54.00 M CAD | 1.00 M CAD | 0.01 CAD |
| 2027e | 77.00 M CAD | 5.00 M CAD | 0.06 CAD |